185 related articles for article (PubMed ID: 21334750)
1. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
Chan T; Barra NG; Lee AJ; Ashkar AA
J Reprod Immunol; 2011 Mar; 88(2):210-8. PubMed ID: 21334750
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
Lee AJ; Ashkar AA
Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
[TBL] [Abstract][Full Text] [Related]
3. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
Milligan GN; Bernstein DI
Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
[TBL] [Abstract][Full Text] [Related]
4. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
Firoz Mian M; Ashkar AA
Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
[TBL] [Abstract][Full Text] [Related]
5. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
Tang VA; Rosenthal KL
J Reprod Immunol; 2010 Dec; 87(1-2):39-44. PubMed ID: 20688399
[TBL] [Abstract][Full Text] [Related]
7. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15.
Gill N; Ashkar AA
Eur J Immunol; 2007 Sep; 37(9):2529-38. PubMed ID: 17668897
[TBL] [Abstract][Full Text] [Related]
8. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
9. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
Milligan GN; Bernstein DI; Bourne N
J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.
Milligan GN; Bernstein DI
Virology; 1997 Mar; 229(1):259-68. PubMed ID: 9123869
[TBL] [Abstract][Full Text] [Related]
11. Pathological effect of IL-17A-producing TCRγδ(+) T cells in mouse genital mucosa against HSV-2 infection.
Kim JO; Cha HR; Kim ED; Kweon MN
Immunol Lett; 2012 Sep; 147(1-2):34-40. PubMed ID: 22698680
[TBL] [Abstract][Full Text] [Related]
12. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
13. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
Parr MB; Parr EL
Virology; 1999 Jun; 258(2):282-94. PubMed ID: 10366565
[TBL] [Abstract][Full Text] [Related]
14. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
[TBL] [Abstract][Full Text] [Related]
15. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
Marks E; Verolin M; Stensson A; Lycke N
Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors, innate immunity and HSV pathogenesis.
Herbst-Kralovetz M; Pyles R
Herpes; 2006 Aug; 13(2):37-41. PubMed ID: 16895653
[TBL] [Abstract][Full Text] [Related]
17. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
18. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
Oh JE; Lee MS; Kim YJ; Lee HK
Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.
Ashkar AA; Yao XD; Gill N; Sajic D; Patrick AJ; Rosenthal KL
J Infect Dis; 2004 Nov; 190(10):1841-9. PubMed ID: 15499542
[TBL] [Abstract][Full Text] [Related]
20. Innate immunity to herpes simplex virus type 2.
Duerst RJ; Morrison LA
Viral Immunol; 2003; 16(4):475-90. PubMed ID: 14733735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
